Real clinical relevance of probiotics supplementation in preventing gastrointestinal adverse events associated with dacomitinib.
Possible determinants of VSL#3 probiotic failure in preventing gastrointestinal adverse events associated with dacomitinib in patients with advanced non-small-cell lung cancer enrolled in ARCHER-1042 trial / Ceccarelli, I; Schietroma, G; Corano Scheri, Giuseppe; D'Ettorre, Gabriella; Vullo, Vincenzo. - In: ANNALS OF ONCOLOGY. - ISSN 0923-7534. - ELETTRONICO. - (2016). [10.1093/annonc/mdw298]
Possible determinants of VSL#3 probiotic failure in preventing gastrointestinal adverse events associated with dacomitinib in patients with advanced non-small-cell lung cancer enrolled in ARCHER-1042 trial
Corano Scheri, Giuseppe;D'ETTORRE, Gabriella;VULLO, Vincenzo
2016
Abstract
Real clinical relevance of probiotics supplementation in preventing gastrointestinal adverse events associated with dacomitinib.File allegati a questo prodotto
| File | Dimensione | Formato | |
|---|---|---|---|
|
Ceccarelli_Possible_2016.pdf
solo gestori archivio
Note: articolo principale
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
42.4 kB
Formato
Adobe PDF
|
42.4 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
